A Phase 1 Clinical Trail of NTQ2494 Tablets in Patients With Advanced Hematological Malignancies
Conditions: Relapsed/Refractory Acute Myeloid Leukemia (AML) Interventions: Drug: NTQ2494 tablet Sponsors: Nanjing Chia-tai Tianqing Pharmaceutical Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Chia | Hematology | Leukemia | Research